An insightful article by Robert Goldberg of the Centers for Medicine in the Public Interest, entitled “The future of drug development,” appeared today on the FiercePharma web site.
Filed under: Business strategy, Drug approvals and regulation, Drug development / clinical trials | Tagged: FDA, future, innovation, NME | Comments Off
